Genenta Science SpA ADR (GNTA)

Currency in USD
1.590
0.000(0.00%)
Closed·
GNTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5901.690
52 wk Range
0.55010.000
Key Statistics
Prev. Close
1.59
Open
1.636
Day's Range
1.59-1.69
52 wk Range
0.55-10
Volume
37.08K
Average Volume (3m)
1.48M
1-Year Change
-57.9365%
Book Value / Share
1.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.978
Upside
+338.90%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Genenta Science SpA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.978
(+338.90% Upside)

Earnings

Latest Release
Apr 01, 2026
EPS / Forecast
-0.13 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GNTA Income Statement

Compare GNTA to Peers and Sector

Metrics to compare
GNTA
Peers
Sector
Relationship
P/E Ratio
−5.1x−4.2x−0.4x
PEG Ratio
−0.16−0.030.00
Price/Book
1.5x2.3x2.6x
Price / LTM Sales
-7.3x2.9x
Upside (Analyst Target)
325.8%227.8%58.0%
Fair Value Upside
Unlock5.6%9.5%Unlock

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
713.88K3.03%1.14M
Other Institutional Investors
5.26M22.28%8.36M
Public Companies & Retail Investors
17.62M74.70%28.02M
Total
23.59M100.00%37.51M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
San Raffaele S.p.A.8.04%1,896,7303,016
Fidim S.P.A3.81%899,7111,431

People Also Watch

4.17
BIYA
+116.06%
0.66
TGHL
-1.97%
10.14
PN
+27.07%
1.89
CAST
-2.07%

FAQ

What Is the Genenta Science ADR (GNTA) Stock Price Today?

The Genenta Science ADR stock price today is 1.590 USD.

What Stock Exchange Does Genenta Science ADR Trade On?

Genenta Science ADR is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Genenta Science ADR?

The stock symbol for Genenta Science ADR is "GNTA."

What Is the Genenta Science ADR Market Cap?

As of today, Genenta Science ADR market cap is 37.510M USD.

What Is Genenta Science ADR's Earnings Per Share (TTM)?

The Genenta Science ADR EPS (TTM) is -0.331.

From a Technical Analysis Perspective, Is GNTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Genenta Science ADR Stock Split?

Genenta Science ADR has split 0 times.

How Many Employees Does Genenta Science ADR Have?

Genenta Science ADR has 9 employees.

What is the current trading status of Genenta Science ADR (GNTA)?

As of Jul 27, 2026, Genenta Science ADR (GNTA) is trading at a price of 1.590 USD, with a previous close of 1.590 USD. The stock has fluctuated within a day range of 1.590 USD to 1.690 USD, while its 52-week range spans from 0.550 USD to 10.000 USD.

What Is Genenta Science ADR (GNTA) Price Target According to Analysts?

The average 12-month price target for Genenta Science ADR is 6.978 USD, with a high estimate of 6.97843413 USD and a low estimate of 6.97843413 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +338.90% Upside potential.

What Is the GNTA Premarket Price?

GNTA's last pre-market stock price is 1.600 USD. The pre-market share volume is 640.000, and the stock has decreased by 0.010, or 0.630%.

What Is the GNTA After Hours Price?

GNTA's last after hours stock price is 1.620 USD, the stock has decreased by 0.030, or 1.890%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.